Source: Annual Congress 2013 –COPD treatment and others
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Gupta, N. Singh, S. Jangir, V. Mishra, R. Kuldeep (Ajmer, India). COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME?. Eur Respir J 2013; 42: Suppl. 57, 3664

Member's Comments

No comment yet.

Related content which might interest you: COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Neoplasia in patients with ILD; shortened survival Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do? Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II) Source: Annual Congress 2013 –COPD treatment Year: 2013 Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Chronic obstructive pulmonary disease as a predictor of lung cancer mortality Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Evaluation of romidepsin (FK228) as a potential therapy for idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Lung function of idiopathic pulmonary fibrosis: Russian IPF registry (Moscow region) Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016